Studies by British and Canadian scientists have led to a curious conclusion: a medicine created to treat a number of oncological diseases, in particular, lung cancer and leukemia, can have a positive effect on the treatment of autism.
It was found that people suffering from Martin-Bell syndrome - a hereditary genetic disease, accompanied by mental retardation, produce an excess amount of protein in the brain. The syndrome refers to diseases of the autistic spectrum. It turned out that the experimental drug "cerkosporid", created to combat lung cancer and leukemia, can block the production of this protein. The result is a qualitative change in the behavioral signs that accompany Martin-Bell syndrome.
Scientists actually state that cercophormide is capable of treating autism.
